Clinical Trial Update: Trial of Antimicrobials Versus Placebo in Addition to Fecal Transplant Therapy in Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating antimicrobials versus placebo as an adjunct to fecal transplant therapy for ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED